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Summary
During muscle differentiation, myoblasts elongate and
fuse into syncytial myotubes [1]. An early event during
this process is the remodeling of the microtubule cyto-
skeleton, involving disassembly of the centrosome
and, crucially, the alignment of microtubules into
a parallel array along the long axis of the cell [2–5].
To further our understanding on how microtubules
support myogenic differentiation, we analyzed the
role of EB1-related microtubule-plus-end-binding pro-
teins. We demonstrate that EB3 [6] is specifically
upregulated upon myogenic differentiation and that
knockdown of EB3, but not that of EB1, prevents myo-
blast elongation and fusion into myotubes. EB3-
depleted cells show disorganized microtubules and
fail to stabilize polarized membrane protrusions. Using
live-cell imaging, we show that EB3 is necessary for the
regulation of microtubule dynamics and microtubule
capture at the cell cortex. Expression of EB1/EB3 chi-
meras on an EB3-depletion background revealed that
myoblast fusion depends on two specific amino acids
in the calponin-like domain of EB3, whereas the inter-
action sites with Clip-170 and CLASPs are dispens-
able. Our results suggest that EB3-mediated micro-
tubule regulation at the cell cortex is a crucial step
during myogenic differentiation and might be a general
mechanism in polarized cell elongation.
Results and Discussion
EB Family Members Are Transcriptionally Regulated
during Myogenic Differentiation
Microtubule integrity is essential for muscle cell differen-
tiation [7–9]. To further our understanding of how the mi-
crotubule cytoskeleton supports myoblast elongation
and fusion, we induced the murine myoblast cell line
C2C12 to differentiate in vitro (see Supplemental
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available online). Within one day, myoblasts elongated
to become spindle shaped, the microtubule cytoskele-
ton was rearranged into a parallel array [4], and centro-
some proteins relocalized to the nuclear periphery
(Figure 1A, Figure S1A). Subsequently, differentiating
myoblasts fused preferentially at the cell tips to form
multinucleated myotubes [10] (Figure 1A). Because the
cell tips are characterized by a high density of microtu-
bule plus ends (data not shown), we studied the poten-
tial role of microtubule tip-binding proteins of the EB
family. Mammalian cells possess three family mem-
bers—EB1, EB2, and EB3 [11]—that share a conserved
domain structure and show high sequence similarity
(Figure S1B). However, we found that murine EB pro-
teins were differentially expressed during myogenesis
(Figures 1B and 1C): Both EB1 mRNA and protein levels
remained constant during differentiation, whereas EB2
expression was rapidly switched off once cells started
to differentiate. In contrast, EB3 that was expressed at
a low basal level in undifferentiated cells was highly up-
regulated early during differentiation (Figures 1B and
1C). The expression pattern of EB1 and EB3 during myo-
genic differentiation was confirmed with primary myo-
blasts from the mouse H-2Kb-tsA58 [12] (Figure S1C).
As in other cell types, EB3 was found to localize to mi-
crotubule plus ends in myoblasts and myotubes (Fig-
ure S1A). Its expression pattern suggested that EB3
might play an important role in the reorganization of
the microtubule cytoskeleton during myogenic differen-
tiation. Because EB2 was shut down immediately, it was
not included in the functional analysis below.
Depletion of EB3 Affects Microtubule Organization
in Myoblasts
In order to study the function of EB proteins, we used
vector-based RNA-interference constructs that allowed
the simultaneous expression of an RNA hairpin and
green fluorescent protein (GFP) as a marker protein to
identify successfully transfected cells [13]. Target se-
quences were chosen to specifically deplete EB1 and
EB3 separately, as well as both proteins simultaneously.
A small hairpin RNA (shRNA) construct targeting firefly
luciferase was used as a control. The depletion efficiency
was 90% or higher for all constructs used (Figure S2).
Different from COS-7 and HeLa S3 cells [14, 15], EB1
depletion in undifferentiated myoblasts seemed to
have no negative effect on the centrosomal focusing of
microtubule minus ends, and microtubule organization
appeared to be normal (Figure S3). However, the deple-
tion of EB3 affected microtubule organization in undiffer-
entiated cells, although EB3 was only expressed at low
levels (Figures 1B and 1C). Microtubule distribution
was uneven, with some areas of the cytoplasm contain-
ing only very few microtubules and other areas be-
ing crowded with curled microtubules (Figure S3). This
phenotype of curled microtubules was even more
pronounced in cells depleted of both EB1 and EB3
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1319Figure 1. EB Proteins during Myogenic Differentiation
(A) Morphological changes and reorganization of the microtubule cytoskeleton. Immunofluorescence of C2C12 cells that were shifted
to differentiation for the times indicated and stained for a-tubulin (red), PCM-1 (green), and DAPI (blue) is shown. The scale bar represents
20 mm.
(B) Reverse-transcription polymerase chain reaction (RT-PCR) of EB1, EB2, EB3, and a-tubulin from RNA isolated from C2C12 myoblasts that
were cultured under differentiation conditions for the times indicated.
(C) Western blots of total cell lysates of C2C12 cells that were cultured under differentiation conditions for the times indicated and probed with
antibodies against EB1, EB2, EB3, and a-tubulin.
(D) C2C12 myoblasts, cultured under differentiation conditions for 41 hr, 3 days after transfection with shRNA constructs against luciferase
(control), EB3, and EB1, coexpressing GFP-tubulin. The scale bar represents 50 mm.
(E) Average of the mean cell length in four to seven cell-elongation experiments after 19–54 hr under differentiation conditions. The average cell
size of undifferentiated myoblasts is included for comparison. Error bars represent the standard deviation (SD).
(F) Myoblast fusion after 54 hr differentiation. GFP-tubulin (white) highlights cells that were transfected with the shRNA constructs (control and
EB3); DNA staining is shown in blue. Clusters of nuclei (arrows) indicate myoblast fusion in both fields of view. Note that cells transfected with
EB3 shRNAs do not participate in fusion. The scale bar represents 100 mm.
(G) Quantification of myoblast-fusion efficiency after 49–54 hr under differentiation conditions. Because of variations between experiments, the
efficiency of cell fusion (percentage of cells containing two or more nuclei) was set to 100% for control cells in each experiment. Columns
represent the average of three to four experiments, and error bars represent the SD.(Figure S3), suggesting that EB1 shares partly redundant
functions with EB3. This is in concordance with previous
reports that EB1 and EB3 have common interacting
partners, such as adenomatosis polyposis coli (APC),
Dynactin, Clip-170, Clasp1, and Clasp2 [16–18], and
that both proteins are redundant in regulating microtu-
bule dynamics [17]. Moreover, EB3 localization at micro-
tubule tips was increased after the depletion of EB1 in
C2C12 cells (Figure S2), further supporting the notion
that EB3 can compensate for the loss of EB1.Depletion of EB3 Impairs Myoblast Elongation
and Fusion
Because we found that EB3 protein expression in-
creased once myoblasts started to differentiate, we
wanted to test whether depletion of EB3 would interfere
with any aspect of differentiation. For this purpose, dif-
ferentiation was induced at least 20 hr after transfection
with shRNA, and cells were analyzed 19 to 54 hr later. At
this time point, most control cells were spindle shaped and
had a mean length of about 110 mm (109.5 6 17.2 mm;
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1320Figures 1D and 1E). The depletion of EB1 did not inter-
fere with cell elongation (Figure 1D): The cell-length dis-
tribution (data not shown) and the mean cell length in
EB1-depleted cells (108.9 6 19.9 mm) were very similar
to those of control cells (Figure 1E). In contrast, deple-
tion of EB3 resulted in significantly shorter cells (59.7 6
7.1 mm; Figures 1D and 1E). For comparison, undifferen-
tiated C2C12 cells have a mean length of 37.66 3.8 mm.
Thus, EB3-depleted cells manage to increase their cell
length upon differentiation by less than 60% of their
original size, whereas control cells elongate to about
3-fold length. Similar data were obtained regardless
of whether GFP or a GFP-tubulin fusion protein were
used as reporter constructs.
In order to analyze the effect of EB1 or EB3 depletion
on myoblast fusion, cells were transfected with shRNA
constructs coexpressing GFP-tubulin, shifted to differ-
entiate after 20–24 hr, and analyzed 50–54 hr later.
Although frequent fusion into syncytial myotubes could
be observed in transfected control cells (Figure 1F), the
depletion of EB3 drastically reduced the number of fused
myoblasts (Figures 1F and 1G). The small proportion of
fused cells that were found among the GFP-tubulin-ex-
pressing cells were undistinguishable from control cells
and usually not effectively depleted of EB3 (data not
shown). This implies that the complete absence of EB3
might not permit myoblast fusion at all. Although clusters
of nuclei indicated syncytial myotubes in the field of view,
cells expressing EB3 shRNAs did not participate in cell
fusion (Figure 1F), suggesting that depletion of EB3
had a dominant effect, probably by interfering with the
acquisition of fusion competence. Although the deple-
tion of EB1 had no effect on cell elongation (see above),
it had minor effects on myoblast fusion and reduced the
number of fused myoblasts to about 80% of control
values (Figure 1G). Because the expression of EB1 hair-
pin constructs increased the frequency of apoptosis (not
shown), the effect on myoblast-fusion efficiency might
be caused solely by the reduction of cell density. In the
double-depletion experiment, only few transfected cells
survived (data not shown), suggesting that the absence
of both EB1 and EB3 during differentiation is lethal.
Expression of Myogenic Markers Is Not Affected
after EB3 Depletion
To further investigate the molecular mechanisms of
EB3-dependent myoblast fusion, we tested whether
EB3 depletion interferes with the timely regulated ex-
pression of transcription factors and structural proteins
that are specific for myogenic differentiation. The ex-
pression level of the muscle-specific transcription factor
myogenin was not notably affected by depletion of EB1
or EB3 (Figure 2A). Likewise, the depletion of EB1 or EB3
had no negative effect on the expression of embryonic
myosin, which is a structural component of the contrac-
tile apparatus and exclusively expressed during myo-
genesis (Figures 2A and 2B). Another early event of myo-
blast differentiation is the relocation of centrosomal
proteins to the nuclear surface. We found no significant
difference in the efficiency with which the centrosome
protein PCM-1 was relocated between control and
EB3-depleted cells (Figure 2C). This suggests that the
reorganization of microtubule minus ends is initiated
correctly. Further, we determined that the stabilizationof microtubules during myogenic differentiation, as indi-
cated by the accumulation of posttranslational tubulin
modifications [19], occurs normally: The levels of acety-
lated (data not shown) and detyrosinated (Glu-) tubulin
were found to be unaltered in EB1- or EB3-depleted
cells (Figure 2A). Taken together, these observations
suggest that myoblasts that were depleted of EB3 prog-
ress through the early steps of myogenesis, and that
their failure to elongate and fuse might be a direct effect
of the limited supply of EB3.
EB3-Depleted Myoblasts Show Defects in Cell
Spreading, Elongation, and Fusion Independently
of the Adhesion to the Extracellular Matrix
Because problems with cell elongation could be caused
by defects in attachment to the extracellular matrix, we
compared the efficiency of a variety of adhesion mole-
cules and artificial substrates to affect cell spreading
in an EB3-depletion background. Most control cells
were spread on polylysine, fibronectin, or collagen after
70 min (Figure S4A2). Although attachment to the sub-
strates was comparable in control and EB3-depleted
cells, significant spreading was observed only in less
than 50% of EB3-depleted cells, on each substrate pro-
vided (Figure S4A). Even those EB3-depleted cells that
spread showed differences from control cells because
they occupied a smaller surface area (Figures S4B and
S4C). Furthermore, providing different surface coatings
Figure 2. Expression of Myogenic Markers Is Not Affected after EB3
Depletion
(A) Western-blot analysis of 20,000 GFP-expressing cells after fluo-
rescence-activated cell sorting (FACS), 3 days after transfection
with shRNA constructs. Blots were probed with antibodies against
EB1, EB3, a-tubulin, myogenin, Glu-tubulin, and embryonic myosin.
Positions of molecular weight markers are indicated on the left.
(B) Immunofluorescence staining for embryonic myosin in EB3-de-
pletion experiments after 55 hr in differentiation conditions. In the
top panel, GFP-tubulin (white) highlights a transfected cell; in the
bottom panel, embryonic myosin staining (white) of the same group
of cells is shown. DNA is shown in blue. Scale bars represent 20 mm.
(C) Immunolocalization of PCM-1 (green) after 55 hr in differentiation
conditions. GFP-tubulin (red) highlights transfected cells with either
control (upper row) or EB3 shRNAs (lower row). DNA is shown in
blue. Scale bars represent 20 mm.
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1321Figure 3. Microtubule Behavior at the Cell Cortex is Altered in EB3-Depleted Cells
(A) Microtubule organization in C2C12 cells 3 days after transfection with shRNA constructs and after 52 hr under differentiation conditions.
GFP-tubulin highlights the microtubule cytoskeleton in transfected cells. The insets show the cell edges of differentiating myoblasts after
49 hr under differentiation conditions. Scale bars represent 20 mm, and 2 mm in the insets.
(B) Microtubule organization in C2C12 cells 3 days after cotransfection of the EB3 shRNA construct and rescue constructs for full-length EB3 or
EB1. GFP-tubulin highlights the microtubule cytoskeleton in transfected cells. Scale bars represent 20 mm.
(C) Images taken from time-lapse movies of GFP-tubulin in shRNA transfected cells that were shifted to differentiation for 49 hr. The time in
seconds is indicated in the upper-right corner. Arrows highlight newly appearing bumps in microtubules that reach the cell cortex and continue
growth. Asterisks indicate the relaxation of such bumps. The scale bar represents 2 mm. See the Supplemental Data for the respective movies.
(D) Quantification of the time microtubule tips spent at or close to the cortex (maximum of 2 mm away). Columns represent data obtained from
93–129 microtubules in five to eight cells, and error bars indicate SD. Microtubule tips spend significantly less time close to the cortex in
EB3-depleted compared to control cells (analysis of variance [ANOVA]: p = 0.0003).
(E) Quantification of the time microtubules continue to grow after reaching the cell cortex, resulting in the introduction of bends into microtubules.
Columns represent data obtained from 38–64 microtubules in four to eight cells, and error bars indicate SD.did not rescue myoblast elongation or fusion efficiency
(Figures S4D and S4E). These data suggest that EB3 de-
pletion does not affect any particular transmembrane
complex for cell adhesion, but instead affects the micro-
tubule-based support of cell spreading and elongation.
Microtubule Behavior at the Cell Cortex Is Altered
in EB3-Depleted Cells
In order to study the influence of EB3 depletion on the mi-
crotubule cytoskeleton, we monitored the behavior ofmicrotubules marked with GFP-a-tubulin in fixed and
live cells. Differentiated control cells showed a dense mi-
crotubule array oriented parallel to the longitudinal axis
of the cell (Figure 3A). EB3-depleted cells often showed
aberrant cell shapes with several short extensions in
various directions but were missing a clear axis. Further-
more, microtubules were disorganized and curled,
a phenotype that was already visible in undifferentiated
cells, although less pronounced (Figure 3A, Figure S3).
Defects in cell shape and microtubule organization in
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1322Figure 4. Rescue of EB3 Depletion
(A) Quantification of myoblast fusion effi-
ciency after 54–55 hr under differentiation
conditions. The efficiency of cell fusion (per-
centage cells containing two or more nuclei)
was set to 1.0 for control cells in each exper-
iment (ranging from 8% to 34% fused cells),
and relative values are shown for all other
constructs. Columns represent an average
of three to four experiments, and error bars
indicate the SD. The columns representing
values not significantly different from those
of control cells (ANOVA: p > 0.05) are shown
in light blue, whereas values not significantly
different from those of EB3 deletion are
shown in orange (ANOVA: p > 0.05). A partial
rescue (which falls in neither of these cate-
gories, with p < 0.02) is shown in yellow.
(B) Western blots of extracts of GFP-positive
cells (after FACS sorting) expressing the res-
cue constructs indicated in Figure S5, as well
as EB3 shRNAs. Blots were probed with anti-
bodies against FLAG and a-tubulin.
(C) Sequence alignment showing the first 53
amino acids of murine EB1 and EB3 (Swiss-
Prot accession numbers Q61166 and Q6PER3,
respectively). Identical amino acids are high-
lighted in blue, similar amino acids in orange,
and sequence differences in yellow and red.
(D) Representation of the amino acid changes
that confer partial rescue to the EB1 construct
in the 3D structure of EB3 N-terminal domain
(PDB accession number 1WYO, model 1,
amino acids 8–137). The putative microtu-
bule-binding site around K89 is shown in
green [22], and the five crucial amino acid
changes between EB1 and EB3 are shown in
magenta or dark red. The image was created
with Protein Explorer 2.78 (http://www.
proteinexplorer.org).
(E) Surface maps of N-terminal domains (amino acids 1–130) of EB1 and EB3 were created with SYBYL 6.9.1 on the basis of PDB files 1PA7 and
1WYO. The four surface-exposed amino acid changes are highlighted in pink and red. Note that the surface structure changes as Y32 in EB3 fills
a deep cleft present in EB1, and amino acids H29 and D26 emanate from the surface of the molecule.EB3-depleted cells were rescued by coexpression of
EB3 with an internal double FLAG tag (Figures 3B and
4B, Figure S5). Equivalent experiments with the respec-
tive EB1 construct failed to rescue (Figure 3B).
Whereas microtubule plus ends extended straight
into the cell cortex in control cells, the formation of curls
was frequently observed in EB3-depleted cells (insets in
Figure 3A). Live-cell imaging of control depleted cells re-
vealed that most microtubules reaching the cortex im-
mediately stopped growing and switched to a dynamic
‘‘captured’’ state with very short, alternating phases of
growth and shrinkage that kept the microtubule plus
ends close to the cell cortex for an extended period of
time (Figures 3C and 3D, Movie S1). The capturing of mi-
crotubules involves the stabilization by rescue factors
(such as CLASPs) that lower the frequency of long depo-
lymerizing phases and increase microtubule longevity
[20]. In addition, microtubule destabilizers (such as
stathmin or kinesin-13 family members) are thought to
trigger depolymerization from microtubule ends that
reach the cell cortex [21] and thus balance the action
of rescue factors to maintain a constant microtubule
length. Live-cell imaging of GFP-labeled microtubules
in EB3-depleted cells revealed defects in both aspects
of cortical microtubule capture: The dwell time ofmicrotubule ends in the cortical area was found to be
reduced 3-fold compared to that of control cells (Fig-
ure 3D, Table 1). In addition, most microtubules contin-
ued growing after reaching the cell borders, resulting in
the bending of the polymer behind the tip (Figures 3C
and 3E, Movie S2). Such behavior was observed on
90% of microtubules in the EB3 knockdown, with micro-
tubules spending on average 20.3 s in the growth phase
after reaching the cortex. In comparison, only about
20% of microtubules in control cells continued growing
for a short period (7.8 s on average), resulting in an aver-
age time of 1.7 s per microtubule observed (Figure 3E).
Expression of EB3-2FLAGi rescued both phenotypes
in cortical microtubule behavior (Table 1). The average
dwell time of microtubule tips at the cell cortex was
5.3 min, which is almost identical to control values
(Figure 3D). Although 58% of microtubules still showed
buckling after hitting the cortex, they did so for a short
period only (6.2 s on average), resulting in an average
time of 3.3 6 0.99 s per microtubule observed (Fig-
ure 3E). This was not significantly different from that of
control cells (analysis of variance (ANOVA): p = 0.098).
These data demonstrate that EB3 is required for the
regulation of microtubule dynamics in a way that allows
microtubule capture at the cell edge.
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Control dEB3 dEB3+EB3 dEB3+EB1 dEB3+EB3-EB1
Fusion efficiency 1.0 0.30 6 0.07 0.93 6 0.10 0.35 6 0.09 0.94 6 0.15
Growth time at cortex (s) 1.7 6 0.28 (n = 64) 20.7 6 6.13 (n = 38) 3.3 6 0.99 (n = 55) 1.8 6 0.88 (n = 54) 1.1 6 0.65 (n = 91)
Percent of microtubules
that ‘‘overgrow’’
21.9% 89.5% 58.2% 38.9% 17.6%
Dwell time at cortex (s) 320 6 120 (n = 130) 106 6 22 (n = 116) 319 6 74 (n = 93) 119 6 62 (n = 154) 343 6 69 (n = 132)
Growth rate (mm/s) 0.165 6 0.065 (n = 94) 0.176 6 0.083 (n = 98) 0.147 6 0.042 (n = 38) 0.139 6 0.057 (n = 40) 0.176 6 0.057 (n = 52)
Shrinkage rate from
cell cortex (mm/s)
0.562 6 0.150 (n = 50) 0.389 6 0.171 (n = 76) 0.520 6 0.130 (n = 40) 0.378 6 0.141 (n = 61) 0.471 6 0.138 (n = 51)In order to test whether other parameters of microtu-
bule dynamic instability were affected, we measured
growth and shrinkage velocities in control and EB3-
depleted cells. Although microtubules grew continu-
ously for shorter periods only in the absence of EB3
(data not shown), microtubule growth speeds were
comparable to those of control cells (Table 1). However,
shrinkage speeds were significantly reduced after EB3
depletion (Table 1). It has to be noted that microtubule
catastrophe events occur at a higher speed when they
originate from the cell cortex than do events induced
in the cytoplasm (cortical: 0.600 6 0.156; cytoplasmic:
0.4316 0.136, n = 19–28 in 3 cells). The cytoplasmic de-
polymerization speed in control cells resembles that of
cortical depolymerizations in EB3-depleted cells, further
supporting the notion that cortical regulation of microtu-
bule dynamics is dependent on EB3. As shown for other
microtubule phenotypes, shrinkage speeds were res-
cued by the expression of a full-length EB3 construct
(Table 1).
The N-Terminal Domain of EB3 Is Necessary
for Its Myogenic Function
Because both EB1 and EB3 share high sequence homol-
ogy, we went on to test which domains of EB3 were con-
ferring myoblast-specific microtubule behavior and
myoblast fusion, by rescuing EB3-depleted cells with
a variety of constructs encoding EB3, EB1, and chi-
maeras of the two proteins. Myoblast-fusion efficiency
was rescued almost completely by coexpressing full-
length EB3-2FLAGi with the EB3 shRNA construct
(Figure 4A). In addition, elongated cell shape, parallel
microtubule organization, and microtubule behavior at
the cell cortex was restored (see above; Figure 3, Table
1). Full-length EB1-2FLAGi could not substitute for the
loss of EB3, indicating that the observed defects are
not caused by the lower amount of total EB proteins
present and that EB3 fulfils a specific function in myo-
blast fusion (Figures 3B and 4A). Next, we constructed
EB1-EB3 chimeras by swapping domains between
these proteins, to map functionally important EB3-spe-
cific regions (Figure S5). The EB3-2FLAG-EB1 construct
fully rescued myoblast fusion, whereas EB1-2FLAG-
EB3 was ineffective (Figure 4A). This finding was unex-
pected because the N-terminal half contains the micro-
tubule-binding region and is highly conserved (82%
identity, 92% homology within first 142 amino acids of
EB1 and EB3). In order to map the crucial region more
accurately, we swapped smaller regions within the N-
terminal domain. Surprisingly, the construct encoding
only the first 53 amino acids of EB3 increased myoblast
fusion efficiency significantly (EB3-EB1-2FLAG-EB1,Figure S5, Figure 4A). EB1 and EB3 differ only in 5 amino
acids in this region, of which three are conservative ex-
changes (Figure 4C). In order to test whether the ex-
changes at positions 29 (Q > H), and 32 (L > Y) are indeed
crucial for the myogenic functions of EB3, we introduced
point mutations to the EB3-2FLAGi rescue construct
that amend H29 or Y32 to the amino acids present in
EB1. Neither EB3H29Q nor EB3Y32L could rescue the
myogenic defects in EB3-depleted cells (Figure 4A). Fi-
nally, we introduced the reverse mutations to EB1, and
although single mutations at Q29H or L32Y were without
effect, the double mutation (EB1Q29H+L32Y) increased its
ability to rescue myoblast fusion significantly (Figure 4A).
Because the binding specificity for microtubule plus
ends is higher for EB3 than it is for EB1 (Figure S6),
and because the crucial region is located in the microtu-
bule-binding domain of EB3, we thought that the differ-
ences in microtubule-binding properties could underlie
the specialized function of EB3. However, both mutated
constructs, EB3H29Q-2FLAGi and EB3Y32L-2FLAGi, lo-
calized as efficiently to the microtubule tips as did
unmutated EB3 (Figure S6). Moreover, these results
demonstrate that the calponin-like domains of EB3 still
fold properly in the presence of the point mutations.
Next, we localized the differing amino acids in the 3D
structure of EB3 (Protein Data Bank [PDB] accession
number 1WYO). Four of the five amino acids are exposed
at the surface of EB3 that is opposite to the proposed
microtubule-binding site [22] (Figure 4D). Because the
exchanges at positions 26 (E > D), 29 (Q > H), and 32
(L > Y) alter the surface of the molecule (Figure 4E),
they could provide an interaction site for a protein that
binds specifically to EB3 but not to EB1.
Clip-170 and CLASPs are interacting proteins of EB3
[17, 18] and were reported to be involved in microtubule
capture at the cell cortex [18, 23]. In order to determine
whether the myogenic function of EB3 involves the inter-
action with these proteins, we tested whether truncated
EB3 lacking the interaction sites would still be able to
rescue the myoblast-fusion phenotype. The deletion of
the C-terminal tyrosine residue from EB3 prevents bind-
ing to Clip-170 [17]. However, the truncated construct
EB3DY-2FLAGi is still able to rescue the myoblast-
fusion defect in EB3-depleted cells (Figure 4A). The de-
letion of the C-terminal acidic tail impairs the binding of
CLASPs to EB1 [18], and presumably to EB3, as well.
Construct EB3DAc-2FLAGi lacks the C-terminal 23
amino acids and partially rescues myoblast-fusion effi-
ciency in dEB3 cells (Figure 4A). These observations
suggest that Clip-170 is not involved in the phenotype
described, whereas CLASPs and other interactors at
the acidic tail appear to play a minor role. However, we
Current Biology
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its calponin-like domain that mediates its differentiation-
specific function.
Finally, we wanted to test whether the calponin-like
domain of EB3 is responsible for the changes in micro-
tubule dynamics at the cell cortex. As described above,
all microtubule phenotypes were rescued by the coex-
pression of EB3-2FLAGi with EB3 shRNAs. In contrast,
EB1-2FLAGi increased neither the dwell time of microtu-
bule plus ends near the cell cortex nor the shrinkage
speeds from the cell cortex (Table 1). However, microtu-
bule ‘‘overgrowing’’ was rescued by the EB1 construct,
suggesting that this phenotype is dependent on the level
of EB proteins, rather than being specific for EB3. We
then used the EB3-2FLAG-EB1 fusion protein that was
competent to fully rescue the myoblast-fusion pheno-
type. EB3-2FLAG-EB1 could fully rescue the dwell time
of microtubule ends at the cell cortex, as well as micro-
tubule overgrowing, and microtubule shrinkage rates
were partially rescued with this construct (Table 1).
These data demonstrate that the calponin-like domain
of EB3 is required for cortical microtubule stabilization,
as well as for the induction of fast catastrophes from
the cell cortex. Efficient myoblast fusion is dependent
on the N terminus of EB3, too, supporting the idea that
EB3-dependent regulation of microtubule dynamics at
the cell cortex is required to provide the cytoskeletal
support for cell elongation and cell-to-cell fusion during
muscle cell differentiation.
How Does EB3 Regulate Microtubules at the Cell
Cortex, and What Are the Implications for the
Differentiating Muscle Cell?
It is difficult to draw a conclusive model about the myo-
genic function of EB3, although its close homolog EB1
and common interactors of EB1 and EB3 have been im-
plicated in various aspects of microtubule-dynamics
regulation. We show that the dwell time of microtubule
ends close to the cell cortex is strongly reduced in the
absence of EB3. This suggests that microtubule capture
and stabilization is impaired in EB3-depleted cells. How-
ever, in their entirety, microtubules are stable and long
lived, as evidenced by regular levels of tubulin modifica-
tions and the presence of long, curled microtubules in
EB3-depleted cells. To understand this paradox, one
should consider that capture of microtubule ends at
the cell cortex is only one of several ways to stabilize mi-
crotubules. The upregulation of a muscle-specific iso-
form of MAP4 early during muscle differentiation [24]
suggests that microtubule stabilization along their
length could also contribute to microtubule longevity.
Moreover, microtubule ends could be stabilized at con-
tact sites with vesicles or organelles in the cytoplasm,
even if cortical capture is compromised in EB3-depleted
cells. Finally, changes in the microtubule depolymeriza-
tion rate, which we found reduced to about 70% after
EB3 depletion, could contribute to the phenotype. It is
thought that depolymerizing kinesins are loaded to
growing microtubule plus ends and become activated
once the microtubule reaches the cell cortex [21]. In
EB3-depleted cells, the loading or activation of microtu-
bule destabilizers might be defective, explaining both
the reduced depolymerization rate and the continuous
growth of plus ends seen at the cortex.Although the different phenotypes of microtubule be-
havior could be caused by separate EB3-dependent
pathways, a general mechanism that underlies the
changes of microtubule dynamic behavior within corti-
cal areas could be affected here. This may involve Rho
family GTPases, such as RhoA, Rac1, and Cdc42, which
have been implicated in microtubule stabilization, to-
gether with their effector proteins [23, 25–28]. RhoGEF2,
an upstream activator of Rho, was shown to travel to the
cell cortex on the tips of growing microtubules by in-
teraction with EB1 [29]. Thus a possible mechanism
by which EB3 regulates cortical-microtubule behavior
could be the targeting of a specific RhoGEF or similar
signaling molecule to the cell cortex. Because Rho-like
GTPases are key regulators of the actin cytoskeleton
and associated integrin adhesion complexes and thus
support cell-shape changes [30], the failure to localize
or activate a Rho family GTPase in the absence of EB3
would also explain the defects in myoblast elongation
we report here. It has been described that cell fusion oc-
curs preferentially at the tips of elongated myoblasts
[10]. We therefore think that successful cell polarization
is a prerequisite to the acquisition of fusion competence
and thus that the myoblast-fusion effect observed in
EB3-depleted cells is a secondary effect, resulting
from defects in cytoskeletal organization and cell polar-
ization. It will be a future challenge to analyze EB3’s pre-
cise role during myogenic differentiation, its effect on
Rho/Rac/Cdc42 signaling, and the interplay with EB-
interacting proteins that modulate microtubule stability
at the cell cortex. Because EB3 is preferentially ex-
pressed in the central nervous system [6], insights
gained from EB3-dependent processes during myogen-
esis might contribute to our understanding of neuronal
differentiation, as well.
Supplemental Data
Experimental Procedures, six figures, and two movies are available
at http://www.current-biology.com/cgi/content/full/17/15/1318/
DC1/.
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